A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder

Journal of Clinical Psychiatry

Volumn 63, Issue 9, 2002, Pages 778-781

  Turkington, Douglas ^a   Grant, John B F ^a   Ferrier, Ian Nicol ^a   Rao, N Sanjay K ^a   Linsley, Keith R ^a   Young, Allan H ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; PLACEBO;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEADACHE; HUMAN; MALE; MOOD; NAUSEA; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SOMATOFORM DISORDER; TREATMENT FAILURE; URINARY TRACT DISEASE; URINE FLOW RATE; VERTIGO;

EID: 0036737072     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0905     Document Type: Article

References (17)

1. World Health Organization. International Classification of Diseases, Tenth Revision. Geneva, Switzerland: World Health Organization; 1992
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
3. Wesselman U, Burnett AL, Heinberg LJ. The urogenital and rectal pain syndromes. Pain 1997;73:263-294
4. Drach GW, Fair WR, Meares EM, et al. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 1978; 120:266
5. Turkington D, Power-Smith P, Grant JBF. Idiopathic genital pain and fluvoxamine [letter]. Br J Psychiatry 1992;160:871
6. Meares EM Jr. Prostatitis. Med Clin North Am 1991;75:405-424
7. Brunner H, Weidner W, Schiefer HC. Studies on the role of Ureaplasma urealyticum and Mycoplasma hominis in prostatitis. J Infect Dis 1983; 126:807-813
8. Leigh DA. Prostatitis: an increasing clinical problem for diagnosis and management. J Antimicrob Chemother 1993;32(suppl A):1-9
9. Fishbain DA, Cutler RB, Rosomoff HL, et al. Do antidepressants reduce pain intensity in psychogenic pain or somatoform pain disorder? a meta-analysis. Psychosom Med 1998;6:503-509
10. Sawynok J, Esser MJ, Reid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999;82:149-158
11. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
12. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
13. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370
14. Goldberg D. The Detection of Psychiatric Illness by Questionnaire. London, England: Oxford University Press; 1972. Maudsley Monographs, No. 21
15. StatsDirect, version 1.8.9. Ashwell, UK: CamCode; 2001
16. Segura JW, Opitz JL, Greene LF. Prostatosis, prostatitis or pelvic floor tension myalgia? J Urol 1979;122:168-169
17. Ciaramella A, Grosso S, Poli P. Fluoxetine versus fluvoxamine for treatment of chronic pain. Minerva Anestesiol 2000;66:55-61